108 related articles for article (PubMed ID: 31061410)
1. MicroRNA-130b functions as an oncomiRNA in non-small cell lung cancer by targeting tissue inhibitor of metalloproteinase-2.
Hirono T; Jingushi K; Nagata T; Sato M; Minami K; Aoki M; Takeda AH; Umehara T; Egawa H; Nakatsuji Y; Kitae K; Ueda Y; Hase H; Yamamoto M; Shinsato Y; Kawahara K; Furukawa T; Tsujikawa K
Sci Rep; 2019 May; 9(1):6956. PubMed ID: 31061410
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-410 acts as oncogene in NSCLC through downregulating SLC34A2 via activating Wnt/β-catenin pathway.
Zhang X; Ke X; Pu Q; Yuan Y; Yang W; Luo X; Jiang Q; Hu X; Gong Y; Tang K; Su X; Liu L; Zhu W; Wei Y
Oncotarget; 2016 Mar; 7(12):14569-85. PubMed ID: 26910912
[TBL] [Abstract][Full Text] [Related]
3. The low expression of miR-451 predicts a worse prognosis in non-small cell lung cancer cases.
Goto A; Tanaka M; Yoshida M; Umakoshi M; Nanjo H; Shiraishi K; Saito M; Kohno T; Kuriyama S; Konno H; Imai K; Saito H; Minamiya Y; Maeda D
PLoS One; 2017; 12(7):e0181270. PubMed ID: 28704499
[TBL] [Abstract][Full Text] [Related]
4. miR-34c-3p targets CDK1 a synthetic lethality partner of KRAS in non-small cell lung cancer.
Palma F; Affinito A; Nuzzo S; Roscigno G; Scognamiglio I; Ingenito F; Martinez L; Franzese M; Zanfardino M; Soricelli A; Fiorelli A; Condorelli G; Quintavalle C
Cancer Gene Ther; 2021 May; 28(5):413-426. PubMed ID: 32948832
[TBL] [Abstract][Full Text] [Related]
5. Overview upon miR-21 in lung cancer: focus on NSCLC.
Bica-Pop C; Cojocneanu-Petric R; Magdo L; Raduly L; Gulei D; Berindan-Neagoe I
Cell Mol Life Sci; 2018 Oct; 75(19):3539-3551. PubMed ID: 30030592
[TBL] [Abstract][Full Text] [Related]
6. Cuproptosis-related gene
Deng R; Zhu L; Jiang J; Chen J; Li H
Biomol Biomed; 2024 May; 24(3):647-658. PubMed ID: 38041690
[TBL] [Abstract][Full Text] [Related]
7. TIMP-2 modulates cancer cell transcriptional profile and enhances E-cadherin/beta-catenin complex expression in A549 lung cancer cells.
Bourboulia D; Han H; Jensen-Taubman S; Gavil N; Isaac B; Wei B; Neckers L; Stetler-Stevenson WG
Oncotarget; 2013 Jan; 4(1):166-76. PubMed ID: 23371049
[TBL] [Abstract][Full Text] [Related]
8. Circ_0017956 promotes the proliferation and metastasis of non-small cell lung cancer through regulating miR-515-5p/ITGB8 axis.
Li N; Zhu D
Cell Cycle; 2021 May; ():1-13. PubMed ID: 33945401
[TBL] [Abstract][Full Text] [Related]
9. Circ_0074027 contributes to non-small cell lung cancer progression through positively modulating RHOA via sequestering miR-2467-3p.
Duan Z; Wei S; Liu Y
J Bioenerg Biomembr; 2021 Apr; 53(2):223-233. PubMed ID: 33687619
[TBL] [Abstract][Full Text] [Related]
10. Curcumin suppresses the malignancy of non-small cell lung cancer by modulating the circ-PRKCA/miR-384/ITGB1 pathway.
Xu X; Zhang X; Zhang Y; Wang Z
Biomed Pharmacother; 2021 Jun; 138():111439. PubMed ID: 33684690
[TBL] [Abstract][Full Text] [Related]
11. circNDUFB2 inhibits non-small cell lung cancer progression via destabilizing IGF2BPs and activating anti-tumor immunity.
Li B; Zhu L; Lu C; Wang C; Wang H; Jin H; Ma X; Cheng Z; Yu C; Wang S; Zuo Q; Zhou Y; Wang J; Yang C; Lv Y; Jiang L; Qin W
Nat Commun; 2021 Jan; 12(1):295. PubMed ID: 33436560
[TBL] [Abstract][Full Text] [Related]
12. Circular RNA circ-CPA4/ let-7 miRNA/PD-L1 axis regulates cell growth, stemness, drug resistance and immune evasion in non-small cell lung cancer (NSCLC).
Hong W; Xue M; Jiang J; Zhang Y; Gao X
J Exp Clin Cancer Res; 2020 Aug; 39(1):149. PubMed ID: 32746878
[TBL] [Abstract][Full Text] [Related]
13. Circ_0072088 promotes the development of non-small cell lung cancer via the miR-377-5p/NOVA2 axis.
Tan Z; Cao F; Jia B; Xia L
Thorac Cancer; 2020 Aug; 11(8):2224-2236. PubMed ID: 32524752
[TBL] [Abstract][Full Text] [Related]
14. Sinomenine Inhibits Migration and Invasion of Human Lung Cancer Cell through Downregulating Expression of miR-21 and MMPs.
Shen KH; Hung JH; Liao YC; Tsai ST; Wu MJ; Chen PS
Int J Mol Sci; 2020 Apr; 21(9):. PubMed ID: 32349289
[TBL] [Abstract][Full Text] [Related]
15. Circular RNA circFGFR1 promotes progression and anti-PD-1 resistance by sponging miR-381-3p in non-small cell lung cancer cells.
Zhang PF; Pei X; Li KS; Jin LN; Wang F; Wu J; Zhang XM
Mol Cancer; 2019 Dec; 18(1):179. PubMed ID: 31815619
[TBL] [Abstract][Full Text] [Related]
16. microRNA-130b May Induce Cerebral Vasospasm after Subarachnoid Hemorrhage via Modulating Kruppel-like Factor 4.
Huang Z; Hu J; Xu J; Wang H; Dai L
Mol Cell Biol; 2023; 43(7):301-316. PubMed ID: 37381993
[TBL] [Abstract][Full Text] [Related]
17. MiR-130b modulates the invasive, migratory, and metastatic behavior of leiomyosarcoma.
Danielson LS; Guijarro MV; Menendez S; Higgins B; Sun Q; Mittal K; Popiolek DA; Overholtzer M; Palmer GD; Hernando E
PLoS One; 2023; 18(1):e0278844. PubMed ID: 36701370
[TBL] [Abstract][Full Text] [Related]
18. Targeting miR-5088-5p attenuates radioresistance by suppressing Slug.
Seok HJ; Choi JY; Yi JM; Bae IH
Noncoding RNA Res; 2023 Jun; 8(2):164-173. PubMed ID: 36632615
[TBL] [Abstract][Full Text] [Related]
19. Ikaros Regulates microRNA Networks in Acute Lymphoblastic Leukemia.
Kogut S; Paculova H; Rodriguez P; Boyd J; Richman A; Palaria A; Schjerven H; Frietze S
Epigenomes; 2022 Oct; 6(4):. PubMed ID: 36278683
[TBL] [Abstract][Full Text] [Related]
20. Construction of miRNA-mRNA networks for the identification of lung cancer biomarkers in liquid biopsies.
Espinosa Garcia E; Arroyo Varela M; Larrosa Jimenez R; Gomez-Maldonado J; Cobo Dols MA; Claros MG; Bautista Moreno R
Clin Transl Oncol; 2023 Mar; 25(3):643-652. PubMed ID: 36229739
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
